92 related articles for article (PubMed ID: 12949799)
1. Overexpression of the beta-catenin binding domain of cadherin selectively kills colorectal cancer cells.
Pierce M; Wang C; Stump M; Kamb A
Int J Cancer; 2003 Nov; 107(2):229-37. PubMed ID: 12949799
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner.
Gottardi CJ; Wong E; Gumbiner BM
J Cell Biol; 2001 May; 153(5):1049-60. PubMed ID: 11381089
[TBL] [Abstract][Full Text] [Related]
3. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
4. Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin.
Venkiteswaran K; Xiao K; Summers S; Calkins CC; Vincent PA; Pumiglia K; Kowalczyk AP
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C811-21. PubMed ID: 12176738
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
Nath N; Kashfi K; Chen J; Rigas B
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
7. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
8. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.
Wong AS; Gumbiner BM
J Cell Biol; 2003 Jun; 161(6):1191-203. PubMed ID: 12810698
[TBL] [Abstract][Full Text] [Related]
9. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex.
Shimokawa T; Furukawa Y; Sakai M; Li M; Miwa N; Lin YM; Nakamura Y
Cancer Res; 2003 Oct; 63(19):6116-20. PubMed ID: 14559787
[TBL] [Abstract][Full Text] [Related]
11. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
[TBL] [Abstract][Full Text] [Related]
13. Identification of Tcf4 residues involved in high-affinity beta-catenin binding.
Omer CA; Miller PJ; Diehl RE; Kral AM
Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
15. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
16. Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis.
Lin YM; Ono K; Satoh S; Ishiguro H; Fujita M; Miwa N; Tanaka T; Tsunoda T; Yang KC; Nakamura Y; Furukawa Y
Cancer Res; 2001 Sep; 61(17):6345-9. PubMed ID: 11522623
[TBL] [Abstract][Full Text] [Related]
17. [Indomethacin induces apoptosis through inhibition of survivin regulated by beta-catenin/TCF4 in human colorectal cancer cells].
Zhu HX; Zhang G; Wang YH; Zhou CQ; Bai JF; Xu NZ
Ai Zheng; 2004 Jul; 23(7):737-41. PubMed ID: 15248904
[TBL] [Abstract][Full Text] [Related]
18. Structure of a human Tcf4-beta-catenin complex.
Poy F; Lepourcelet M; Shivdasani RA; Eck MJ
Nat Struct Biol; 2001 Dec; 8(12):1053-7. PubMed ID: 11713476
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
Wang Q; Sun Z; Yang HS
Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
[TBL] [Abstract][Full Text] [Related]
20. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
